This residual CD4 elevation supports the idea that helper T-cell–driven inflammation may persist longer, potentially contributing to chronic neuroinflammatory states observed in demyelinating diseases like multiple sclerosis [51]. The gene discussed is CD4; the disease is demyelinating disease.